Clinical Outcomes of MICROPURE and PodEye Monofocal Intraocular Lenses
Launched by BEAVER-VISITEC INTERNATIONAL, INC. · Jan 4, 2019
Trial Information
Current as of May 20, 2025
Completed
Keywords
ClinConnect Summary
This clinical investigation is a prospective, non-randomised, open, controlled, single-center post-market clinical follow whereby study patients undergoing routine cataract surgery will have implantation of monofocal intraocular lens Micropure 1.2.3. (PhysIOL, Liège, Belgium) in one eye and implantation of monofocal intraocular lens PODEYE (PhysIOL, Liège, Belgium) in the contralateral eye of the same patient.
The study purpose is to obtain clinical data on visual acuity and contrast sensitivity on patients implanted with Micropure 1.2.3. and PODEYE
The devices under investigation (Microp...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cataractous eyes with no comorbidity
- • Availability, willingness and sufficient cognitive awareness to comply with examination procedures
- • Clear intraocular media other than cataract;
- • Signed informed consent
- Exclusion Criteria:
- • Age of patient \< 45 years;
- • Irregular astigmatism;
- • Regular corneal astigmatism \>0.75 dioptres by an automatic keratometer or biometer or \>1.0 dioptres if the steep axis of cylinder is between 90° and 120°;
- • Difficulty for cooperation (distance from their home, general health condition);
- • Previous intraocular or corneal surgery;
- • Traumatic cataract;
- • Any ocular comorbidity;
- • Instability of keratometry or biometry measurements.
About Beaver Visitec International, Inc.
Beaver-Visitec International, Inc. is a leading global medical device company specializing in innovative surgical solutions for ophthalmic and other medical specialties. With a commitment to advancing patient care, the company focuses on developing high-quality, innovative products that enhance surgical precision and improve clinical outcomes. Leveraging extensive research and development expertise, Beaver-Visitec collaborates with healthcare professionals to address unmet needs in the operating room, thereby transforming surgical practices and enhancing patient safety. Through its dedication to excellence and innovation, Beaver-Visitec continues to play a pivotal role in the evolution of surgical technologies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zlin, , Czechia
Patients applied
Trial Officials
Pavel Stodůlka, MD, PhD
Principal Investigator
Gemini Eye Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials